Latest News & Features
Big Pharma
UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs. 27 June 2023
Europe
Dame Sue Carr takes over from Lord Burnett of Maldon, assuming responsibilities in October. 22 June 2023
Americas
Commission argues that a New York federal court erred in its finding that deals between an AbbVie unit and generic manufacturers were justified | US Supreme Court previously ruled that “unjustified” reverse payments can violate the antitrust laws. 22 June 2023
Americas
Pharma company claims infringement of both patents that cover the blockbuster treatment | Generic version has been in motion since May last year. 22 June 2023
Big Pharma
Pharma giant claims infringement of two patents |
Hyderabad-based rival’s letter offering details of proposed generic allegedly lacked certain required details. 20 June 2023
Americas
Both drug treatments inhibit a protein called Bruton’s tyrosine kinase that can trigger cancer | Lawsuit comes in wake of patent grant for disputed drug | New study caused headaches for AbbVie’s subsidiary. 20 June 2023
Americas
The three-year dispute revolved around proposed generic versions of a drug used to offset the effects of muscle relaxants | Pharma giant can retain patent until January 2026. 15 June 2023
Americas
Deal thought to be aimed at helping pharma giant attain sales target as patents start to expire | Israeli drugmaker will join with Icelandic firm to unveil a copycat version of blockbuster treatment by 2025. 14 June 2023
Americas
Win marks latest leg of cross-Atlantic litigation feud over devices that stop internal bleeding | Medical device maker garnered success against rival in the US and Germany but failed to secure an injunction in one European country. 13 June 2023
Big Pharma
Promosome claimed it shared mRNA tech with the trio, who went on to make hugely successful vaccines | The small biotech wants a cut of more than $100 billion allegedly made by the big pharma companies. 8 June 2023